Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Dose-dependent effects of oral dronedarone on the circadian variation of RR and QT intervals in healthy subjects: implications for antiarrhythmic actions.
J Cardiovasc Pharmacol Ther. 2006 Sep;11(3):184-90. doi: 10.1177/1074248406290678.
J Cardiovasc Pharmacol Ther. 2006.
PMID: 17056831
Clinical Trial.
Rate-dependence of antiarrhythmic drug action.
Singh BN, Wadhani N, Sarma JS.
Singh BN, et al. Among authors: wadhani n.
J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):203-6. doi: 10.1177/107424840200700401.
J Cardiovasc Pharmacol Ther. 2002.
PMID: 12490964
Review.
No abstract available.
Item in Clipboard
Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.
Singh BN, Wadhani N.
Singh BN, et al. Among authors: wadhani n.
J Cardiovasc Pharmacol Ther. 2004 Sep;9 Suppl 1:S85-97. doi: 10.1177/107424840400900107.
J Cardiovasc Pharmacol Ther. 2004.
PMID: 15378133
Review.
Item in Clipboard
Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm.
Srivatsa U, Wadhani N, Singh BN.
Srivatsa U, et al. Among authors: wadhani n.
Curr Cardiol Rep. 2002 Sep;4(5):401-10. doi: 10.1007/s11886-002-0040-6.
Curr Cardiol Rep. 2002.
PMID: 12169237
Review.
Item in Clipboard
Prolongation of repolarization as antifibrillatory action revisited: drug combination therapy in atrial fibrillation.
Wadhani N, Singh BN.
Wadhani N, et al.
J Cardiovasc Pharmacol Ther. 2005 Sep;10(3):149-52. doi: 10.1177/107424840501000301.
J Cardiovasc Pharmacol Ther. 2005.
PMID: 16211202
No abstract available.
Item in Clipboard
Lipid-lowering therapy in patients with peripheral arterial disease.
Ebrahimi R, Saleh JR, Toggart EJ, Hayatdavoudi B, Wolf CJ, Wadhani NN, Shah AP.
Ebrahimi R, et al. Among authors: wadhani nn.
J Cardiovasc Pharmacol Ther. 2004 Dec;9(4):271-7. doi: 10.1177/107424840400900407.
J Cardiovasc Pharmacol Ther. 2004.
PMID: 15678246
Review.
Item in Clipboard
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.
Moliterno DJ; TENACITY Steering Committee and Investigators.
Moliterno DJ, et al.
Catheter Cardiovasc Interv. 2011 Jun 1;77(7):1001-9. doi: 10.1002/ccd.22876. Epub 2011 Jan 11.
Catheter Cardiovasc Interv. 2011.
PMID: 21598351
Clinical Trial.
Item in Clipboard
Cite
Cite